News Center

We have expanded our clinical testing portfolio with the launch of two new germline assays designed to address the unique...

Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...

Everyone has some risk of developing cancer. In fact, nearly 40% of people will be diagnosed with cancer at some...

Everyone has some risk of developing cancer. Most often cancer is caused by mutations that arise as a consequence of...